| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cholesterol O-acyltransferase activity | 2.66e-05 | 3 | 60 | 2 | GO:0034736 | |
| GeneOntologyMolecularFunction | sterol O-acyltransferase activity | 2.66e-05 | 3 | 60 | 2 | GO:0004772 | |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 2.66e-05 | 3 | 60 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 2.66e-05 | 3 | 60 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 2.66e-05 | 3 | 60 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 5.31e-05 | 4 | 60 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 5.31e-05 | 4 | 60 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 2.46e-04 | 8 | 60 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.51e-04 | 102 | 60 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | tRNA (cytidine) methyltransferase activity | 3.93e-04 | 10 | 60 | 2 | GO:0016427 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 4.80e-04 | 11 | 60 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | steroid binding | 6.87e-04 | 133 | 60 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | cholesterol binding | 7.08e-04 | 58 | 60 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | sterol binding | 1.27e-03 | 71 | 60 | 3 | GO:0032934 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.40e-03 | 161 | 60 | 4 | GO:0019842 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 1.80e-03 | 21 | 60 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA binding | 1.97e-03 | 22 | 60 | 2 | GO:0000062 | |
| GeneOntologyMolecularFunction | fatty acid derivative binding | 2.35e-03 | 24 | 60 | 2 | GO:1901567 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 2.75e-03 | 26 | 60 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 2.75e-03 | 26 | 60 | 2 | GO:0120227 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 2.97e-03 | 27 | 60 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 3.19e-03 | 28 | 60 | 2 | GO:0005242 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.72e-03 | 211 | 60 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 3.90e-03 | 31 | 60 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 4.68e-03 | 34 | 60 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | tRNA methyltransferase activity | 4.68e-03 | 34 | 60 | 2 | GO:0008175 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 5.69e-03 | 238 | 60 | 4 | GO:0016747 | |
| Domain | NECAP_PHear | 9.48e-06 | 2 | 58 | 2 | IPR012466 | |
| Domain | SID1_TM_fam | 9.48e-06 | 2 | 58 | 2 | IPR025958 | |
| Domain | SID-1_RNA_chan | 9.48e-06 | 2 | 58 | 2 | PF13965 | |
| Domain | Sterol_acyltranf_meta | 9.48e-06 | 2 | 58 | 2 | IPR030687 | |
| Domain | DUF1681 | 9.48e-06 | 2 | 58 | 2 | PF07933 | |
| Domain | Oat_ACAT_DAG_ARE | 2.84e-05 | 3 | 58 | 2 | IPR014371 | |
| Domain | MeTrfase | 5.66e-05 | 4 | 58 | 2 | IPR026113 | |
| Domain | TDE1/TMS | 9.42e-05 | 5 | 58 | 2 | IPR005016 | |
| Domain | Serinc | 9.42e-05 | 5 | 58 | 2 | PF03348 | |
| Domain | Methyltransf_12 | 1.41e-04 | 6 | 58 | 2 | PF08242 | |
| Domain | Methyltransf_12 | 1.41e-04 | 6 | 58 | 2 | IPR013217 | |
| Domain | MBOAT_fam | 5.12e-04 | 11 | 58 | 2 | IPR004299 | |
| Domain | MBOAT | 5.12e-04 | 11 | 58 | 2 | PF03062 | |
| Domain | Glyco_trans_31 | 1.11e-03 | 16 | 58 | 2 | IPR002659 | |
| Domain | Galactosyl_T | 1.11e-03 | 16 | 58 | 2 | PF01762 | |
| Domain | AMP-bd_C | 1.25e-03 | 17 | 58 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.25e-03 | 17 | 58 | 2 | PF13193 | |
| Domain | PH_dom-like | 2.02e-03 | 426 | 58 | 6 | IPR011993 | |
| Domain | AMP-binding_CS | 2.94e-03 | 26 | 58 | 2 | IPR020845 | |
| Domain | AMP_BINDING | 3.40e-03 | 28 | 58 | 2 | PS00455 | |
| Domain | AMP-binding | 3.90e-03 | 30 | 58 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 3.90e-03 | 30 | 58 | 2 | IPR000873 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 1.29e-04 | 6 | 42 | 2 | MM14693 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 1.80e-04 | 7 | 42 | 2 | MM14598 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 2.60e-04 | 42 | 42 | 3 | M16743 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 3.08e-04 | 9 | 42 | 2 | M27959 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 3.08e-04 | 9 | 42 | 2 | MM15707 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 3.08e-04 | 9 | 42 | 2 | M26968 | |
| Pathway | WP_DOPAMINE_METABOLISM | 6.62e-04 | 13 | 42 | 2 | M39622 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 8.63e-04 | 381 | 42 | 6 | M48063 | |
| Pathway | KEGG_STEROID_BIOSYNTHESIS | 1.15e-03 | 17 | 42 | 2 | M5872 | |
| Pathway | REACTOME_LDL_CLEARANCE | 1.29e-03 | 18 | 42 | 2 | MM15565 | |
| Pathway | REACTOME_LDL_CLEARANCE | 1.43e-03 | 19 | 42 | 2 | M27846 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 1.43e-03 | 19 | 42 | 2 | M27452 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 1.43e-03 | 19 | 42 | 2 | MM15194 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19634011 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16521160 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 18269457 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15992359 | ||
| Pubmed | Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. | 2.93e-06 | 2 | 60 | 2 | 22811412 | |
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 2.93e-06 | 2 | 60 | 2 | 28785058 | |
| Pubmed | Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. | 2.93e-06 | 2 | 60 | 2 | 26982734 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 29948332 | ||
| Pubmed | Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. | 2.93e-06 | 2 | 60 | 2 | 14729857 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16647063 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26067272 | ||
| Pubmed | Identification of a ubiquitous family of membrane proteins and their expression in mouse brain. | 2.93e-06 | 2 | 60 | 2 | 10637174 | |
| Pubmed | Organization of human ACAT-2 gene and its cell-type-specific promoter activity. | 2.93e-06 | 2 | 60 | 2 | 11401500 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 18000807 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15158756 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16230498 | ||
| Pubmed | B3GNT9 B3GNT3 KLHL8 CHI3L2 METTL2A MMP14 ACSM2A CDC42BPB METTL2B | 4.28e-06 | 730 | 60 | 9 | 34857952 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9756920 | ||
| Pubmed | Dysregulated expression of sterol O-acyltransferase 1 (Soat1) in the hair shaft of Hoxc13 null mice. | 8.77e-06 | 3 | 60 | 2 | 26321246 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 32427860 | ||
| Pubmed | Mutually exclusive substrate selection strategy by human m3C RNA transferases METTL2A and METTL6. | 1.75e-05 | 4 | 60 | 2 | 34268557 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 20133765 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 15308631 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 22669916 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 32830538 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 11738826 | ||
| Pubmed | Identification of a family of endocytic proteins that define a new alpha-adaptin ear-binding motif. | 1.75e-05 | 4 | 60 | 2 | 14555962 | |
| Pubmed | Cellular pregnenolone esterification by acyl-CoA:cholesterol acyltransferase. | 1.75e-05 | 4 | 60 | 2 | 22474282 | |
| Pubmed | Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans. | 2.92e-05 | 5 | 60 | 2 | 28655767 | |
| Pubmed | Generation of Cre transgenic mice with postnatal RPE-specific ocular expression. | 2.92e-05 | 5 | 60 | 2 | 21212186 | |
| Pubmed | 4.43e-05 | 225 | 60 | 5 | 12168954 | ||
| Pubmed | B3GNT9 SIDT2 SERINC1 KRTDAP NBEAL2 B3GNT3 CLEC19A HEPH METTL2B | 4.57e-05 | 985 | 60 | 9 | 12975309 | |
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 9756919 | ||
| Pubmed | Definition of the consensus motif recognized by gamma-adaptin ear domains. | 1.05e-04 | 9 | 60 | 2 | 14665628 | |
| Pubmed | 2.26e-04 | 13 | 60 | 2 | 16396906 | ||
| Pubmed | Association study of the serotoninergic system in migraine in the Spanish population. | 4.40e-04 | 18 | 60 | 2 | 19455600 | |
| Pubmed | 4.51e-04 | 86 | 60 | 3 | 19501082 | ||
| Pubmed | Unravelling the complex genetics of cleft lip in the mouse model. | 4.91e-04 | 19 | 60 | 2 | 11353389 | |
| Pubmed | Pet-1 is required across different stages of life to regulate serotonergic function. | 5.45e-04 | 20 | 60 | 2 | 20818386 | |
| Pubmed | 5.45e-04 | 20 | 60 | 2 | 23637192 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.99e-04 | 1105 | 60 | 8 | 35748872 | |
| Pubmed | Subtype specification of GABAergic amacrine cells by the orphan nuclear receptor Nr4a2/Nurr1. | 6.02e-04 | 21 | 60 | 2 | 19692620 | |
| Pubmed | 6.02e-04 | 21 | 60 | 2 | 18270970 | ||
| Pubmed | 6.90e-04 | 407 | 60 | 5 | 12693553 | ||
| Pubmed | 7.23e-04 | 23 | 60 | 2 | 21937600 | ||
| Pubmed | Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo. | 7.88e-04 | 24 | 60 | 2 | 22537018 | |
| Pubmed | TSHZ1-dependent gene regulation is essential for olfactory bulb development and olfaction. | 7.88e-04 | 24 | 60 | 2 | 24487590 | |
| Pubmed | 8.56e-04 | 25 | 60 | 2 | 20301702 | ||
| Pubmed | 8.56e-04 | 25 | 60 | 2 | 19372376 | ||
| Pubmed | 1.07e-03 | 28 | 60 | 2 | 35942939 | ||
| Pubmed | 1.17e-03 | 266 | 60 | 4 | 19380743 | ||
| Pubmed | 1.32e-03 | 31 | 60 | 2 | 30254141 | ||
| Pubmed | Genetic associations of brain structural networks in schizophrenia: a preliminary study. | 1.32e-03 | 31 | 60 | 2 | 20691427 | |
| Pubmed | Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. | 1.32e-03 | 31 | 60 | 2 | 19898483 | |
| Pubmed | 1.43e-03 | 128 | 60 | 3 | 23858473 | ||
| Pubmed | Convergence of the insulin and serotonin programs in the pancreatic β-cell. | 1.58e-03 | 34 | 60 | 2 | 22013016 | |
| Pubmed | 1.68e-03 | 35 | 60 | 2 | 28031476 | ||
| Cytoband | 16p12.3 | 1.23e-05 | 34 | 60 | 3 | 16p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 1.39e-03 | 167 | 60 | 3 | chr1q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 1.51e-03 | 172 | 60 | 3 | chr16p12 | |
| GeneFamily | Beta 3-glycosyltransferases | 9.23e-04 | 24 | 34 | 2 | 426 | |
| GeneFamily | Acyl-CoA synthetase family | 1.08e-03 | 26 | 34 | 2 | 40 | |
| GeneFamily | Methyltransferase like | 1.75e-03 | 33 | 34 | 2 | 963 | |
| GeneFamily | Ubiquitin specific peptidases | 4.96e-03 | 56 | 34 | 2 | 366 | |
| Coexpression | SANSOM_APC_TARGETS_REQUIRE_MYC | 1.48e-05 | 231 | 60 | 6 | MM737 | |
| Coexpression | GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP | 2.59e-05 | 152 | 60 | 5 | M343 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 5.08e-05 | 175 | 60 | 5 | M6690 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 5.97e-05 | 181 | 60 | 5 | M8662 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 9.34e-05 | 199 | 60 | 5 | M5564 | |
| Coexpression | GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP | 9.34e-05 | 199 | 60 | 5 | M5687 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 9.56e-05 | 200 | 60 | 5 | M9472 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 9.56e-05 | 200 | 60 | 5 | M6044 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP | 9.56e-05 | 200 | 60 | 5 | M6947 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.70e-05 | 403 | 60 | 8 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 2.01e-05 | 19 | 60 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 3.65e-05 | 23 | 60 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_100 | 4.72e-05 | 25 | 60 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP53 CALB1 DDX25 SHPRH SERINC3 DEPDC5 HBZ RASAL2 SOAT1 EPM2AIP1 | 5.78e-05 | 776 | 60 | 10 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | USP53 B3GNT9 CALB1 SHPRH SERINC3 DEPDC5 MMP14 RASAL2 SOAT1 EPM2AIP1 | 7.07e-05 | 795 | 60 | 10 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | USP53 CALB1 SHPRH SERINC3 DEPDC5 MMP14 HBZ RASAL2 SOAT1 EPM2AIP1 | 7.76e-05 | 804 | 60 | 10 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | USP53 ETNK2 AKR1B15 SERINC3 DEPDC5 MMP14 HBZ RASAL2 SOAT1 EPM2AIP1 | 7.92e-05 | 806 | 60 | 10 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_200 | 8.66e-05 | 159 | 60 | 5 | gudmap_developingGonad_e14.5_ testes_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 9.11e-05 | 31 | 60 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500 | 1.54e-04 | 411 | 60 | 7 | gudmap_developingGonad_e14.5_ testes_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 2.62e-04 | 44 | 60 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_500 | 3.05e-04 | 114 | 60 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_500 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-06 | 182 | 60 | 5 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| Drug | cyclandelate | 2.83e-06 | 11 | 60 | 3 | CID000002893 | |
| Drug | DMPH4 | 2.83e-06 | 11 | 60 | 3 | CID000073578 | |
| Drug | AC1Q6A3R | 6.83e-06 | 2 | 60 | 2 | CID000160583 | |
| Drug | gypsetin | 6.83e-06 | 2 | 60 | 2 | CID000160406 | |
| Drug | glisoprenin B | 6.83e-06 | 2 | 60 | 2 | CID006438769 | |
| Drug | NSC292654 | 6.83e-06 | 2 | 60 | 2 | CID000325064 | |
| Drug | 23-methyl-UDCA | 6.83e-06 | 2 | 60 | 2 | CID000196679 | |
| Drug | 7,7-difluorocholestanol | 6.83e-06 | 2 | 60 | 2 | CID000196646 | |
| Drug | 6,6-difluorocholestanol | 6.83e-06 | 2 | 60 | 2 | CID000196647 | |
| Drug | Aplus | 6.83e-06 | 2 | 60 | 2 | CID000028221 | |
| Drug | Ro 16-0521 | 6.83e-06 | 2 | 60 | 2 | CID000065657 | |
| Drug | AC1NT076 | 6.83e-06 | 2 | 60 | 2 | CID005321102 | |
| Drug | xymedon | 6.83e-06 | 2 | 60 | 2 | CID000121931 | |
| Drug | L-DOPA methyl ester | 9.51e-06 | 16 | 60 | 3 | CID000023497 | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.28e-05 | 196 | 60 | 6 | 2528_UP | |
| Drug | olean-12-ene | 2.05e-05 | 3 | 60 | 2 | CID000612780 | |
| Drug | Purpactin A | 2.05e-05 | 3 | 60 | 2 | CID000131673 | |
| Drug | glisoprenin A | 2.05e-05 | 3 | 60 | 2 | CID006438768 | |
| Drug | Nsc692258 | 2.05e-05 | 3 | 60 | 2 | CID000469167 | |
| Drug | ethyl 6-chlorochroman-2-carboxylate | 2.05e-05 | 3 | 60 | 2 | CID000169516 | |
| Drug | zaragozic acid D3 | 2.05e-05 | 3 | 60 | 2 | CID006475792 | |
| Drug | 2-S-cysteinyldopa | 2.05e-05 | 3 | 60 | 2 | CID000160007 | |
| Drug | 5-OH-dopa | 2.05e-05 | 3 | 60 | 2 | CID000161161 | |
| Drug | AC1NUTWC | 4.08e-05 | 4 | 60 | 2 | CID005460914 | |
| Drug | Cgs-26214 | 4.08e-05 | 4 | 60 | 2 | CID000133077 | |
| Drug | AC1L3QAA | 4.08e-05 | 4 | 60 | 2 | CID000093484 | |
| Drug | isochromophilone VII | 4.08e-05 | 4 | 60 | 2 | CID006443571 | |
| Drug | isochromophilone VIII | 4.08e-05 | 4 | 60 | 2 | CID006443572 | |
| Drug | Metergoline | 4.08e-05 | 4 | 60 | 2 | ctd:D008711 | |
| Drug | acaterin | 4.08e-05 | 4 | 60 | 2 | CID000126830 | |
| Drug | acetic acids | 5.44e-05 | 28 | 60 | 3 | CID000031229 | |
| Drug | AC1L2WGH | 6.79e-05 | 5 | 60 | 2 | CID000129916 | |
| Drug | v La | 6.79e-05 | 5 | 60 | 2 | CID000160637 | |
| Drug | 8-hydroxygenistein | 6.79e-05 | 5 | 60 | 2 | CID005492944 | |
| Drug | N-beta-alanyldopamine | 6.79e-05 | 5 | 60 | 2 | CID000162755 | |
| Drug | NSC-110264 | 6.79e-05 | 5 | 60 | 2 | CID000269324 | |
| Drug | aminoparathion | 1.02e-04 | 6 | 60 | 2 | CID000000220 | |
| Drug | butyl butyrate | 1.02e-04 | 6 | 60 | 2 | CID000007983 | |
| Drug | SCH 48461 | 1.02e-04 | 6 | 60 | 2 | CID000132832 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.15e-04 | 181 | 60 | 5 | 1077_UP | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.52e-04 | 192 | 60 | 5 | 5620_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.56e-04 | 193 | 60 | 5 | 4276_UP | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.59e-04 | 194 | 60 | 5 | 4531_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.59e-04 | 194 | 60 | 5 | 1628_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 5341_UP | |
| Drug | (+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 1.67e-04 | 196 | 60 | 5 | 837_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 7408_UP | |
| Drug | (-)-quinpirole hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 1.71e-04 | 197 | 60 | 5 | 456_UP | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 3877_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 1532_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 1499_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 4158_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 1689_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 6267_UP | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.79e-04 | 199 | 60 | 5 | 3198_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.79e-04 | 199 | 60 | 5 | 1009_UP | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A | 1.79e-04 | 199 | 60 | 5 | 5836_DN | |
| Drug | Simvastatin [79902-63-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 3340_DN | |
| Drug | isobutyramide | 1.86e-04 | 42 | 60 | 3 | CID000068424 | |
| Drug | CP-113,818 | 1.89e-04 | 8 | 60 | 2 | CID000164373 | |
| Drug | 4-methylumbelliferyl elaidate | 1.89e-04 | 8 | 60 | 2 | CID000087585 | |
| Drug | vanillyl alcohol | 1.89e-04 | 8 | 60 | 2 | CID000062348 | |
| Drug | arjunolic acid | 1.89e-04 | 8 | 60 | 2 | CID000073641 | |
| Drug | Methyldopa | 1.89e-04 | 8 | 60 | 2 | ctd:D008750 | |
| Drug | mecoprop | 2.13e-04 | 44 | 60 | 3 | CID000007153 | |
| Drug | benzyl benzoate | 2.43e-04 | 9 | 60 | 2 | CID000002345 | |
| Drug | cetyl ether | 2.43e-04 | 9 | 60 | 2 | CID000077757 | |
| Drug | phenacemide | 2.43e-04 | 9 | 60 | 2 | CID000004753 | |
| Drug | propanoyl | 2.43e-04 | 9 | 60 | 2 | CID000139982 | |
| Drug | AC1L2O7B | 2.43e-04 | 9 | 60 | 2 | CID000125213 | |
| Drug | PD138142-15 | 2.43e-04 | 9 | 60 | 2 | CID003025787 | |
| Drug | bromopropylate | 3.03e-04 | 10 | 60 | 2 | CID000028936 | |
| Drug | N-methylisatoic anhydride | 3.03e-04 | 10 | 60 | 2 | CID000025160 | |
| Drug | 6-hydroxydopa | 3.03e-04 | 10 | 60 | 2 | CID000033755 | |
| Drug | AC1L9BFY | 3.03e-04 | 10 | 60 | 2 | CID000441673 | |
| Drug | stearoylcarnitine | 3.03e-04 | 10 | 60 | 2 | CID000005282 | |
| Disease | X-21319 measurement | 4.07e-06 | 2 | 60 | 2 | EFO_0800807 | |
| Disease | X-11478 measurement | 1.22e-05 | 3 | 60 | 2 | EFO_0021242 | |
| Disease | 3-hydroxyhexanoate measurement | 4.05e-05 | 5 | 60 | 2 | EFO_0800378 | |
| Disease | indoleacetoylcarnitine measurement | 6.07e-05 | 6 | 60 | 2 | EFO_0800106 | |
| Disease | cholesteryl ester 24:4 measurement | 8.48e-05 | 7 | 60 | 2 | EFO_0021447 | |
| Disease | cholesteryl ester 24:5 measurement | 2.65e-04 | 12 | 60 | 2 | EFO_0021448 | |
| Disease | nevus count, cutaneous melanoma | 8.55e-04 | 91 | 60 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 1.09e-03 | 24 | 60 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 1.38e-03 | 27 | 60 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | anti-basement membrane glomerulonephritis (biomarker_via_orthology) | 1.71e-03 | 30 | 60 | 2 | DOID:4780 (biomarker_via_orthology) | |
| Disease | microcephaly (implicated_via_orthology) | 1.94e-03 | 32 | 60 | 2 | DOID:10907 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DHDLFSFADLIFGKW | 296 | Q0P6H9 | |
| KDACWFHLAIFDFFT | 341 | P28222 | |
| FSVNWFILFNDALVH | 931 | Q96Q42 | |
| PAKFNFASDVLDHWA | 41 | Q08AH3 | |
| AALLHFFFLAAFTWM | 931 | Q9HAR2 | |
| FINLLSFDFHGSWEK | 206 | Q15782 | |
| GFFEHLEKWFDQCSL | 881 | Q9P1Z9 | |
| FDQADTFRPAEFHWK | 431 | Q9H4D0 | |
| VEFADSFNFNPHKWL | 291 | P20711 | |
| LLFSATFEDSVWHFA | 276 | Q9UHL0 | |
| FFKGDKHWVFDEASL | 381 | P50281 | |
| APDFLAFKEHFSLAW | 281 | Q86VS3 | |
| FASDISELWALFAHF | 206 | Q8N3Y3 | |
| LFWCIAFFHGDLEAS | 76 | P48050 | |
| IFAHLEEAWSFLDAF | 191 | Q9Y257 | |
| GNFSLNAAFEIKLHW | 1376 | O75140 | |
| VQVNKFALASHFFWA | 331 | Q9NVF9 | |
| SFIFEANEAWKDFHG | 41 | Q9P2G9 | |
| SAFKADEFLNWHALF | 56 | P60985 | |
| ENGFFKDRHWLFTEF | 86 | Q6P1Q9 | |
| KADNIFWGEHFEFFS | 206 | Q9UJF2 | |
| NFWLHKLVFVDAVAF | 286 | P52848 | |
| FKKHAFFEGLNWENI | 336 | Q9Y5S2 | |
| ENGFFKDRHWLFTEF | 86 | Q96IZ6 | |
| ADFTAEAHAAWDKFL | 116 | P02008 | |
| GAWLEKNFAAFFSHI | 316 | Q86XA9 | |
| HFSDKQWLCDFGFLV | 371 | Q7L775 | |
| ITASQFFEIWLHFDA | 11 | P05937 | |
| GDILQWDFHDSFFNL | 171 | Q9Y2A9 | |
| WDFHDSFFNLTLKQV | 176 | Q9Y2A9 | |
| FFFHDTPKEEEWFKA | 391 | P32019 | |
| FWDQFHVSFNKSELF | 151 | Q9H488 | |
| FFAFLHCWLNAFAEM | 381 | P35610 | |
| DFFDDHDIWHFLSSI | 791 | Q8NBJ9 | |
| VEHDHETFWLFQFFL | 176 | Q8IYX1 | |
| QHLLFNFHLWTLSDF | 1021 | Q6ZNJ1 | |
| FFLLFSVVDENLSWH | 226 | Q9BQS7 | |
| YHFDNSWKAFLGELT | 106 | Q149N8 | |
| VHNGFWFFKFAAAIA | 121 | Q9NRX5 | |
| FAFLHCWLNAFAEML | 356 | O75908 | |
| WRAFDFKEFSHLEDF | 296 | C9JRZ8 | |
| FFNLTLKEIHFLAWA | 201 | Q6UX72 | |
| PAKFNFASDVLDHWA | 41 | Q68CK6 | |
| LWAAAFLTLHSAQAF | 6 | Q6UXS0 | |
| AFHTKSSKWVFFDDA | 306 | Q70EK8 | |
| FHKVGFADFWLADQL | 386 | Q9UBH6 | |
| FDLHWAAVTLANNFK | 186 | Q15468 | |
| ARVHWAFKFFDSQGA | 41 | Q7Z2Z1 | |
| FFNDFSDHLAEEALW | 1041 | Q13905 | |
| AFHNAHDLSKWDLFA | 696 | Q8N3U4 | |
| DFFDDHDIWHFLSAT | 786 | Q9NXL6 | |
| FADENNEKLFSAWAA | 236 | Q15035 | |
| LWFLHDQNSSAFKFY | 816 | Q8IX01 | |
| FLLHHAFVDSIFEQW | 386 | P14679 | |
| LDHLFDCFKASWTNA | 466 | O00507 | |
| AIFDLEGWQFSHAFQ | 156 | P49638 | |
| TWVFDNVKDFFHHAR | 176 | O95427 | |
| RAAVHNGFWFFKIAA | 126 | Q13530 | |
| KFAFEEFHLWYQFAL | 391 | Q86TV6 | |
| AFDFNVSLQDHFKWV | 116 | Q8NC96 | |
| FDFNVALQDHFKWVK | 116 | Q9NVZ3 |